Security Snapshot

Lantern Pharma Inc. - Common Stock, $0.0001 par value per share (LTRN) Institutional Ownership

CUSIP: 51654W101

13F Institutional Holders and Ownership History from Q2 2020 to Q4 2025

Latest Period

Q4 2025

Institutions Reporting

33

Shares (Excl. Options)

2,280,306

Price

$3.03

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Common Stock, $0.0001 par value per share
Symbol
LTRN on Nasdaq
Shares outstanding
11,176,471
Price per share
$3.03
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
2,280,306
Total reported value
$6,910,016
% of total 13F portfolios
0%
Share change
-4,043
Value change
-$64,644
Number of holders
33
Price from insider filings
$3.03
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Sponsored

Quick Takeaways

  • LTRN - Lantern Pharma Inc. - Common Stock, $0.0001 par value per share is tracked under CUSIP 51654W101.
  • 33 institutions reported positions in Q4 2025.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 31 to 33 between Q3 2025 and Q4 2025.
  • Reported value moved from $9,928,721 to $6,910,016.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 33 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 51654W101?
CUSIP 51654W101 identifies LTRN - Lantern Pharma Inc. - Common Stock, $0.0001 par value per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Lantern Pharma Inc. - Common Stock, $0.0001 par value per share (LTRN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Bios Equity Partners, LP 8.6% -14% $2,908,879 -$351,256 960,026 -11% BIOS CAPITAL MANAGEMENT, LP 20 Feb 2026
SATTERFIELD THOMAS A JR 5.1% $1,727,100 570,000 Thomas A. Satterfield, Jr. 30 Mar 2026

As of 31 Dec 2025, 33 institutional investors reported holding 2,280,306 shares of Lantern Pharma Inc. - Common Stock, $0.0001 par value per share (LTRN). This represents 20% of the company’s total 11,176,471 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Lantern Pharma Inc. - Common Stock, $0.0001 par value per share (LTRN) together control 20% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BIOS Capital Management, LP 9% 1,009,507 -0.61% 3.7% $3,058,806
VANGUARD GROUP INC 3.4% 384,041 0% 0% $1,163,644
CM Management, LLC 2% 225,000 0% 0.57% $681,750
RENAISSANCE TECHNOLOGIES LLC 0.99% 110,400 +10% 0% $334,512
GEODE CAPITAL MANAGEMENT, LLC 0.87% 96,742 +5.1% 0% $293,191
Voss Capital, LP 0.45% 50,000 0% 0.01% $151,500
BlackRock, Inc. 0.4% 44,253 +2.7% 0% $134,087
DIMENSIONAL FUND ADVISORS LP 0.35% 39,110 -2.6% 0% $118,503
NewEdge Advisors, LLC 0.34% 38,069 -19% 0% $115,354
Westside Investment Management, Inc. 0.32% 35,900 0% 0.02% $108,780
CITADEL ADVISORS LLC 0.29% 32,895 0% $99,672
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.26% 28,820 -26% 0% $87,325
HORIZON KINETICS ASSET MANAGEMENT LLC 0.25% 27,582 -4.2% 0% $83,573
Bank of New York Mellon Corp 0.24% 26,481 0% 0% $80,237
DAVENPORT & Co LLC 0.21% 23,814 -7.7% 0% $72,156
STATE STREET CORP 0.21% 23,652 0% 0% $71,666
Focus Partners Wealth 0.14% 15,982 0% $48,426
NORTHERN TRUST CORP 0.14% 15,589 0% 0% $47,235
CIBC Private Wealth Group LLC 0.14% 15,432 0% $46,759
Cetera Investment Advisers 0.11% 12,228 0% $37,051
UBS Group AG 0.1% 10,627 -68% 0% $32,200
GROUP ONE TRADING LLC 0.04% 4,072 -20% 0% $12,338
SIMPLEX TRADING, LLC 0.02% 2,257 +58% 0% $6,838
SBI Securities Co., Ltd. 0.02% 2,143 0% 0% $6,493
CURIO WEALTH, LLC 0.02% 2,000 0% $6,680

Institutional Holders of Lantern Pharma Inc. - Common Stock, $0.0001 par value per share (LTRN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 2,280,306 $6,910,016 -$64,644 $3.03 33
2025 Q3 2,284,349 $9,928,721 +$166,361 $4.35 31
2025 Q2 2,241,170 $7,081,768 -$615,229 $3.16 34
2025 Q1 2,423,714 $8,580,099 -$194,908 $3.54 30
2024 Q4 2,499,825 $7,996,845 -$160,960 $3.19 32
2024 Q3 1,335,871 $4,902,351 +$118,888 $3.67 31
2024 Q2 1,286,016 $6,005,302 +$572,129 $4.67 39
2024 Q1 1,108,429 $9,753,422 +$324,907 $8.80 33
2023 Q4 1,155,318 $4,944,504 +$6,767 $4.28 29
2023 Q3 1,153,745 $3,934,035 -$18,036 $3.41 26
2023 Q2 1,152,036 $6,497,253 +$385,814 $5.64 25
2023 Q1 1,083,678 $5,233,851 +$124,192 $4.83 21
2022 Q4 893,594 $5,395,811 -$1,734,422 $6.04 21
2022 Q3 1,436,757 $6,840,000 +$106,232 $4.78 23
2022 Q2 1,417,902 $8,060,000 -$230,429 $5.70 25
2022 Q1 1,452,881 $10,384,000 -$1,687,241 $7.14 25
2021 Q4 1,658,393 $13,121,000 -$563,118 $7.98 31
2021 Q3 1,400,629 $15,656,000 +$604,001 $11.18 24
2021 Q2 1,346,716 $19,660,000 -$1,578,997 $14.60 19
2021 Q1 1,403,470 $25,458,000 +$23,880,194 $18.14 21
2020 Q4 82,988 $1,597,009 -$1,643,167 $19.24 10
2020 Q3 160,127 $3,017,000 +$710,980 $18.84 11
2020 Q2 122,153 $1,551,000 +$1,551,000 $12.39 5

Sponsored